(Grey's) Anatomy of an Opioid Crisis

The popular medical drama gets it right—with a little romance on the side, naturally

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Grey’s Anatomy, the long-running ABC medical drama, has a history of being socially relevant, bringing attention in recent years to racial profiling, the #MeToo movement, immigration reform—and now the nation’s opioid crisis.

More than 130 Americans die every day after overdosing on opioids, according to the National Institute on Drug Abuse. And the most recent statistics available show that more than 47,000 Americans died in 2017 as a result of an opioid overdose. So, when one of the most popular shows on network television makes opioid misuse a major plotline, we paid especially rapt attention to how the show would present this public health crisis. How closely would it mirror reality? Pretty close, for the narrow slice of the opioid crisis it addressed.

The story arc debuted a couple of weeks ago when more than 50 patients who overdosed on opioids at a nearby Seattle park end up at the fictional Grey Sloan Memorial Hospital. The episode illustrated that the opioid crisis knows no boundaries, showing a wide range of characters struggling with the disease—a young man, a homeless youth, a seemingly stay-at-home middle-class mom. Overwhelmed doctors shouted out orders that often involved using Narcan, the brand name for a drug called naloxone that can save a life by reversing the effects of an opioid overdose.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The opioids storyline continues the next week when two doctors with a potential love connection—it is Grey’s after all—attend a medical conference. One will speak about prescribing opioids, the other is a recovering addict. Leading a session, Link, the orthopedic surgeon portrayed by Chris Carmack, recounts operating on a high school soccer goalie who injured his knee during a game and prescribing opioids for the pain. When the athlete died two years later in a car accident while under the influence, the doctor says he realized his unintentional role in the tragedy. Even knowing the outcome, the surgeon says he’d prescribe opioids all over again. Before he can explain how and why, the other Grey’s doctor walks out.

The tension in that moment could represent the real-life tension across the medical and public health communities about whether opioids should be prescribed—and if so, how?

Given that the country is in the midst of the largest drug crisis in U.S. history, efforts to dramatically decrease the amount of opioids are widespread, with some doctors deciding not to prescribe opioids at all. The American Medical Association suggests that opioids continue to be a useful clinical tool for effective pain reduction, if prescription guidelines are followed.

Research is being conducted that could lead to improved prescribing and monitoring of opioids. For certain injuries and procedures, such as surgery, opioids have been proven to be effective pain relievers. Screening tools can help identify patients who might be at risk if they were prescribed opioids, including those with a history of substance use disorders or who show signs they might misuse the drugs.

Prescribers are supposed to first consider if non-opioid pain killers and other approaches to managing pain such as physical therapy and acupuncture might be effective. If opioids are used, they should be prescribed conservatively—meaning using the smallest doses for as brief a period as possible to manage the pain. And patients who require a longer-term opioid prescription are at higher risk for misuse and need to be monitored more carefully.

Putting these guidelines into practice can present challenges. Doctors who screen a patient for potential red flags, such as previous history with substance use disorders, may not have access to the patient’s full medical history. Some patients struggling with addiction may choose to hide their pasts. Even those regarded as lower-risk candidates for misusing opioids might find that their doctor, who is often already stretched thin, has limited time to oversee what is a time- and resource-intensive process. And while there are a range of alternative approaches to manage pain that are effective, they may not be covered by insurance, further limiting patient access.

On Grey’s Anatomy, the rest of Link’s opioids presentation occurs off-camera, but it likely followed some version of the updated approach for prescribing opioids. When he shows up at the hotel room of his colleague, he says, “You missed the good part, the error of my ways and all that.” They vow to fight the opioid crisis together, and another Grey’s romance takes flight.

Despite the usual soapy backdrop, the medical drama delivered a simple and powerful message about the pain-killing power of opioids and the importance of putting clear and structured guidelines into practice. Millions of people watch Grey’s every week. With luck, they were listening, too.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe